Charleston, SC -- (SBWIRE) -- 09/18/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: Cell Therapeutics Inc (NASDAQ:CTIC), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Gerdau SA (ADR)(NYSE:GGB), Amarin Corporation plc (ADR)(NASDAQ:AMRN)
Cell Therapeutics Inc (NASDAQ:CTIC) settled +10.48% higher at $1.37 on above-normal volume of 5.96M shares during the last trading day. The stock has its 12-month high at $3.14 and 52-week low price was $0.97. It traded in a range of $1.21 to $1.49 during the last trading day.
Cell Therapeutics, Inc. engages in the acquisition, development, and commercialization of treatments for cancer.
Why Should Investors Buy CITC After the Recent Fall? Just Go Here and Find Out
In the last trading session, Inovio Pharmaceuticals Inc (NYSEMKT:INO) was down on low volume, trading at a volume of 5.79M versus its average daily volume of 13.03 million shares. At $2.35, the stock has attained market capitalization of 446.27 million.
Why Should Investors Buy INO After the Recent Fall? Just Go Here and Find Out
Gerdau SA (ADR)(NYSE:GGB) managed to keep its gain/ at 0.27% on below-normal volume of 5.61M shares. The stock settled at $7.41 after floating in a range of $7.36 to $7.49. Its latest price has reached market capitalization of $12.60 billion. Its 52-week range has been $5.27 to $10.35. Gerdau S.A. engages in the production and commercialization of steel products worldwide.
Where GGB is Headed Exactly? Find out in This Trend Analysis Reports
Amarin Corporation plc (ADR)(NASDAQ:AMRN) traded down on a volume of 5.33million, higher than its standard daily volume. Shares have dropped -2.13% to $6.44. Over the last twelve months, the stock has lost -54.52% and faced a worst price of $5.12.
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases.
Is AMRN a Solid Investment at These Levels? Read This Report for Details
About Impressive Penny Stocks
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)